SR

Srinivas Ramaiah Nidichenametla

Active Director Managing Director DIN 00045562
DIN 00045562 First appointment May 2008 Primary industry Chemicals and Materials
Unlock full profile Investments · shareholding · contact details
Current companies 3 active board seats
Past companies 1 historical roles
Total affiliations 4 Since May 2008
Shareholding value •••• Premium profile

About Srinivas Ramaiah Nidichenametla

Data last updated:

Srinivas Ramaiah Nidichenametla is a Managing Director at Ocimum Life Sciences Private Limited (since 2012), Director at Mana Effluent Treatment Plant Limited (since 2012) and Director at Enaaar Life Sciences Private Limited (since 2020). The companies operate in Chemicals and Materials, Environment and Chemicals. The 2 current companies with reported revenue have a combined latest revenue of ₹13.73 Cr; the largest is Ocimum Life Sciences Private Limited at ₹7.02 Cr (FY 2025). Earlier, Srinivas Ramaiah Nidichenametla was a Director at Biosyn Research Chemicals Private Limited (2008–2012).

DIN 00045562
Primary Designation Managing Director
Industry Chemicals and Materials
First Appointment 29 May 2008
Oldest Company Age 14 yrs
Largest company Ocimum Life Sciences Private Limited · ₹7.02 Cr (FY 2025)
Combined revenue ₹13.73 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Ocimum Life Sciences Private Limited U24240TG2012PTC083812
Managing Director23 Oct 20122012₹7.02 Cr (FY 2025)Active
Director28 Jul 20122011₹6.71 Cr (FY 2025)Active
Enaaar Life Sciences Private Limited U24232TG2020PTC139428
Director20 Feb 20202020Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director29 May 20082008₹3.75 Cr (FY 2024)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Enaaar Life Sciences Private Limited
Ocimum Life Sciences Private Limited
Mana Effluent Treatment Plant Limited
Biosyn Research Chemicals Private Limited
Premium access

Shareholding and investment profile for Srinivas Ramaiah Nidichenametla

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Srinivas Ramaiah Nidichenametla

Srinivas Ramaiah Nidichenametla currently holds 3 directorships: Ocimum Life Sciences Private Limited (Managing Director, since 23 Oct 2012, revenue ₹7.02 Cr (FY 2025)); Mana Effluent Treatment Plant Limited (Director, since 28 Jul 2012, revenue ₹6.71 Cr (FY 2025)); Enaaar Life Sciences Private Limited (Director, since 20 Feb 2020).

Srinivas Ramaiah Nidichenametla was first appointed on 29 May 2008 as Director at Biosyn Research Chemicals Private Limited. The most recent appointment on record is 20 Feb 2020 at Enaaar Life Sciences Private Limited.

The 2 current companies of Srinivas Ramaiah Nidichenametla that report revenue have a combined latest revenue of ₹13.73 Cr: Ocimum Life Sciences Private Limited ₹7.02 Cr (FY 2025); Mana Effluent Treatment Plant Limited ₹6.71 Cr (FY 2025).

Srinivas Ramaiah Nidichenametla held 1 earlier board appointment: Biosyn Research Chemicals Private Limited (Director, 29 May 2008 to 28 Sep 2012).

The current boards of Srinivas Ramaiah Nidichenametla's companies include Kalyani Nidichenametla (Ocimum Life Sciences Private Limited), Nidichenametla Ajay (Ocimum Life Sciences Private Limited), Thirupathireddy Yalluri (Ocimum Life Sciences Private Limited), Dinesh Kumar Jain (Mana Effluent Treatment Plant Limited), Kishan Chandra Kondepati (Mana Effluent Treatment Plant Limited), Kothireddy Mahender Reddy (Mana Effluent Treatment Plant Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available